Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-06
DOI
10.3389/fimmu.2021.763292
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19
- (2021) Shaul Lev et al. PLoS One
- Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients
- (2021) Lili Li et al. Frontiers in Immunology
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
- (2021) Arvinder S Soin et al. Lancet Respiratory Medicine
- SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients
- (2021) Marton Olbei et al. Frontiers in Immunology
- IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression
- (2021) Emmanuel Tharmarajah et al. JOURNAL OF INFECTION
- Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration
- (2021) Ruirong Chen et al. Frontiers in Immunology
- Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic options
- (2021) Shetty Ravi Dyavar et al. BIOMEDICINE & PHARMACOTHERAPY
- Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
- (2021) Patrícia O. Guimarães et al. NEW ENGLAND JOURNAL OF MEDICINE
- Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction
- (2021) Jiajia Wang et al. Virology Journal
- Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort
- (2021) Maria J. Pons et al. Frontiers in Immunology
- Cytokine Signature Associated With Disease Severity in COVID-19
- (2021) Jing Guo et al. Frontiers in Immunology
- Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study
- (2020) Jian Wu et al. CLINICAL INFECTIOUS DISEASES
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
- (2020) Yang Yang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19
- (2020) Grace Lui et al. JOURNAL OF INFECTION
- Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
- (2020) Jing Liu et al. EBioMedicine
- Prevalence of Asymptomatic SARS-CoV-2 Infection
- (2020) Daniel P. Oran et al. ANNALS OF INTERNAL MEDICINE
- Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
- (2020) Ying Chi et al. JOURNAL OF INFECTIOUS DISEASES
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease
- (2020) Yan Zhao et al. JCI Insight
- The laboratory tests and host immunity of COVID-19 patients with different severity of illness
- (2020) Feng Wang et al. JCI Insight
- Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 ARDS
- (2020) Sophie Hue et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge
- (2020) Maja Buszko et al. NATURE IMMUNOLOGY
- An inflammatory cytokine signature predicts COVID-19 severity and survival
- (2020) Diane Marie Del Valle et al. NATURE MEDICINE
- Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
- (2020) Prabhu S. Arunachalam et al. SCIENCE
- IL-10 Has Differential Effects on the Innate and Adaptive Immune Systems of Septic Patients
- (2019) Monty Mazer et al. JOURNAL OF IMMUNOLOGY
- Unique Action of Interleukin-18 on T Cells and Other Immune Cells
- (2018) Kenji Nakanishi Frontiers in Immunology
- CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats
- (2017) Shan Lang et al. PLoS One
- Alternative activation generates IL-10 producing type 2 innate lymphoid cells
- (2017) Corey R. Seehus et al. Nature Communications
- Regulation of Adaptive Immunity; The Role of Interleukin-10
- (2013) T. H. Sky Ng et al. Frontiers in Immunology
- Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
- (2011) Wenjun Ouyang et al. Annual Review of Immunology
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- Monocyte Chemoattractant Protein-1 (MCP-1), Not MCP-3, Is the Primary Chemokine Required for Monocyte Recruitment in Mouse Peritonitis Induced with Thioglycollate or Zymosan A
- (2009) M. Takahashi et al. JOURNAL OF IMMUNOLOGY
- IL-10 and the resolution of infections
- (2007) CM Filippi et al. JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now